Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany

We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in 2004–2006. In 177 (4%) of 4,557 culture-positive TB cases, Mycobacterium tuberculosis isolates were identified as MDR TB; an additional 7 (0...

Full description

Bibliographic Details
Main Authors: Barbara Eker, Johannes Ortmann, Giovanni B. Migliori, Giovanni Sotgiu, Ralf Muetterlein, Rosella Centis, Harald Hoffmann, Detlef Kirsten, Tom Schaberg, Sabine Ruesch-Gerdes, Christoph Lange
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2008-11-01
Series:Emerging Infectious Diseases
Subjects:
tuberculosis
drug-resistance
MDR TB
XDR TB
linezolid
Germany
Online Access:https://wwwnc.cdc.gov/eid/article/14/11/08-0729_article

Internet

https://wwwnc.cdc.gov/eid/article/14/11/08-0729_article

Similar Items